Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GKM New Pharma is an Indian pharmaceutical formulation and contract manufacturing company based in Puducherry, India. Founded in 2007, the company specializes in the manufacturing, supply, and export of a wide range of pharmaceutical products, including tablets, capsules, and liquid oral suspensions. GKM New Pharma operates a WHO-GMP compliant manufacturing facility with an annual production capacity of hundreds of millions of tablets and capsules. Its product portfolio spans multiple therapeutic areas, featuring formulations such as antiulcerants, cardiovascular drugs, antidiabetics, and antibiotics, including active ingredients like lafutidine, rosuvastatin, clopidogrel, and balofloxacin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GKM New Pharma.